CD274 and cancer: Cancer cells exploit this dual capacity of the immune system by not only over-producing immune-inhibiting signaling molecules (e.g. check point proteins like PD-L1) that block their destruction but by producing signals that stimulate the immune system's potential to foster cell proliferation as well.